During the past decade, CHU de la Réunion conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 5 clinical trials were completed, i.e. on average, 6.1% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 5 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de la Réunion" #1 sponsor was "Centre Hospitalier Universitaire de la Réunion" with 52 trials, followed by "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials sponsored, "University Hospital, Toulouse" with 3 trials sponsored, "Centre Leon Berard" with 2 trials sponsored and "French Society for Intensive Care" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de la Réunion" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 2 trials as a collaborator, "Universite de La Reunion" with 2 trials as a collaborator, "APLAMEDOM" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "CHU de la Réunion" are "COVID-19" (2 trials), "Chikungunya" (2 trials), "Chikungunya Fever" (2 trials), "Coronavirus" (2 trials) and "Cystic Fibrosis" (2 trials). Many other conditions were trialed in "CHU de la Réunion" in a lesser frequency.

Most popular intervention types in "CHU de la Réunion" are "Other" (37 trials), "Drug" (18 trials), "Device" (7 trials), "Procedure" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "data collection" (3 trials), "Carboplatin" (2 trials), "IPP-201101" (2 trials) and "Thiotepa" (2 trials). Other intervention names were less common.

The vast majority of trials in "CHU de la Réunion" are 84 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de la Réunion". 9 are not yet recruiting, 30 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in CHU de la Réunion, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de la Réunion, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 28 trials that are defined as “Not Applicable".

CHU de la Réunion has several departments that took part in Clinical trials: "Centre Hospitalier Regional Sud Reunion; Service de Pneumologie" - 3 trials, "Department of endocrinology, University Hospital Reunion Island - Felix Guyon Site" - 2 trials